Skip to main content

Deals

Inflexion’s Rosemont Pharmaceuticals to acquire Aytu BioPharma in take-private deal

Tuesday, November 17, 2026 · first reported by PEI Private Equity

Rosemont Pharmaceuticals, backed by Inflexion, will acquire Aytu BioPharma in a take-private deal.

Also named
Rosemont Pharmaceuticals, Aytu BioPharma
Asset class
Private equity

Terms Take-private

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

See an error?

Get every deal like this one in FundOps Daily. Free, every morning by 7:30am ET.

Read each morning at 190+ firms: GPs, LPs, and fund service providers. See a sample edition

Got news? Send it to us →